Beyond mixed case lettering: reducing the risk of wrong drug errors requires a multimodal response.
Beyond mixed case lettering: reducing the risk of wrong drug errors requires a multimodal response.
复制标题
除了混合大小写字母之外：降低用药错误的风险需要多模式响应。
DOI：
10.1136/bmjqs-2022-014841
复制
发表时间：
2023
影响因子：
5.4
通讯作者：
Paparella,Susan
中科院分区：
文献类型：
--
作者：
Lambert,BruceL;Schroeder,ScottRyan;Cohen,MichaelR;Paparella,Susan
Lohmeyer等人研究了混合病例(通常被称为“高个子”)文本增强对重症监护护士从一系列类似标签的注射器中正确识别特定注射器的能力的影响。1在这里，我们对他们的研究进行反思，总结其主要发现，评论其优势，并建议这一研究领域的进一步发展。然后，我们提出，显著、可靠地减少药品名称混淆错误将需要多模式干预。
Lohmeyer et al examined the effect of mixed case (often referred to as ‘tall man’) text enhancement on critical care nurses’ ability to correctly identify a specific syringe from an array of similarly labelled syringes. 1 Here, we reflect on their study, summarising its key findings and commenting on its strengths as well as suggesting further developments in this field of research. We then make the case that significant, reliable reduction in drug name confusion errors will require multimodal interventions.